Gene therapy via CRISPR/Cas9-mediated Cxcr4 disease allele inactivation reverses leukopenia in WHIM mice

Journal:
Journal of Clinical Investigation
Published:
DOI:
10.1172/jci202073
Affiliations:
1
Authors:
7
Go to article
Institutions Authors Share
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)
7.000000
 1.00
Interested in Agricultural Biotechnology?